Dr. Duangpun Kritchanchai walked us through the benefits of an integrated digital supply chain for COVID-19 Medical Supply by GTIN and the opportunities for reengineering the health system.

• Dr. Duangpun Kritchanchai, Associate Professor, Centre of Logistics Management and Healthcare Supply Chain (LogHealth), Mahidol University, Thailand

Hear from Professor Moji Christianah Adeyeye, Director General of National Agency for Food & Drugs Administration and Control (NAFDAC) in Nigeria about the traceability efforts that were put in motion for enabling the traceability of the COVID-vaccines.

The HSE in collaboration with GS1 Ireland adopted a GS1 standards-based approach for the identification and traceability.

As COVID-19 vaccines became available, Ireland’s Health Service Executive (HSE) needed an efficient and effective way of receiving, administering, tracking and reporting vaccinations across its more than 40 Centralised Vaccination Clinics.

The ACT Health team acted quickly and took advantage of its knowledge and existing use of GS1 standards.

When the COVID-19 virus hit Australia, the Australian Capital Territory’s health system (ACT Health) faced the challenge of containment, testing and administering vaccinations.

The efforts required to ensure safe vaccines supply chain.

The third edition ​covered greater details of the experience around the world in managing the complex supply chain through to the patient administration process, to reduce the risk from falsified and diverted Covid-19 Vaccines.

• Hanno Ronte: Partner Deloitte
• Ken Leggins: UNICEF Chief Supply Chain Strengthening Centre, Supply Division
• Grant Courtney: UNICEF Consultant
• Peter O’Halloran: Chief Information Officer ACT Health

The optimization of the vaccines roll-out using GS1 Standards in Ireland, New-Zealand and Turkey.

Senior executives discussed their work about developing a verification system in digital healthcare to reduce the risk from falsified and diverted COVID-19 vaccines.

• Suzanne Mc Donald: Deloitte Ireland Consulting Partner – Health & Social Care Lead
• Dr Peter Stevens: GS1 New-Zealand CEO
• Shiobain Duggan: GS1 Ireland Director of Innovation & Healthcare
• Ozgur Yilmaz Gomec: VISIOTT - Head of Sales & Business Developments

The unprecendent collaboration to protect people and in the future worldwide.

Senior executive discussed their work about having a secure and efficient supply chain which creates Trust.

• Gregory Reh: Global Life Sciences & Healthcare Leader
• Tjalling van der Schoors: Director of Professional Development EAHP
• Lisa Hedman: WHO – Group Lead |Supply & Access to Medicines
• Tom Woods: Chairman of the Global Steering Committee Assurance of Health Products of the World Bank
• Zigmars Sebris: Regulatory Affairs Officer at the Human Research & Development Support Division